Clearwater Analytics Holdings, Inc. (CWAN) entered a merger agreement on January 13, 2025, to acquire Enfusion, Inc. (ENFN) for $1.5 billion in a cash-plus-stock transaction.
Under the terms of the merger agreement, Enfusion shareholders will receive $11.25 per share, split into $5.85 in cash and $5.40 per share in Clearwater Common Stock; representing a 13.18% premium over Enfusion’s last close as of January 10, 2025.